Health food functional evaluation testing provides the scientific evidence required to substantiate physiological function claims for health foods and dietary supplements before registration and market entry. This article explains the regulatory framework, sample requirements, functional test categories, animal and human trial methodologies, and practical applications of functional evaluation programs. Understanding these requirements helps manufacturers plan compliant testing schedules and prepare robust claim-substantiation dossiers.
Technical Overview
Health food functional evaluation testing refers to the systematic battery of animal experiments, human feeding trials, and laboratory biomarker analyses used to verify whether a health food product delivers its declared physiological function. It forms the technical core of health food registration dossiers in regulated markets and determines whether a manufacturer may legally attach a function claim to the product label.
In China, health foods carrying the official registration mark must undergo functional evaluation in accordance with nationally issued technical guidelines for health function testing and assessment. The functional program is complemented by safety and quality testing: toxicological safety is assessed under the GB 15193 series, microbiological hygiene under the GB 4789 series, physical and chemical analysis under the GB 5009 series, contaminant limits under GB 2762, and overall product compliance under GB 16740, the national food safety standard for health foods. In international markets, equivalent claim-substantiation programs follow structure/function claim notification principles in the United States and health claim authorization requirements in the European Union.
All studies should be performed in accredited third-party laboratories operating under ISO/IEC 17025 management systems and internationally recognized Good Laboratory Practice (GLP) principles, with human trials additionally conducted under ethics committee approval and informed consent procedures.
- Verify that the product delivers its declared health function claim
- Establish dose–response relationships and effective dosage ranges
- Demonstrate biological plausibility of the claimed mechanism
- Confirm consistency between animal results and human outcomes
- Support label claims, registration filings, and marketing compliance
Testing Samples
Finished Dosage Forms
Representative commercial formulations are required, including tablets, hard and soft capsules, granules, oral liquids, powders, and functional beverages. Samples must reflect the final production process, excipient composition, and recommended daily intake. Submission typically includes one to three production batches, with total quantities commonly in the range of 10 to 30 kilograms or an amount sufficient to cover the full test schedule plus reserve, as specified by the testing laboratory.
Raw Materials and Functional Ingredients
Botanical extracts, bioactive peptides, probiotic cultures, vitamins, minerals, and other functional ingredients are characterized for identity, marker compound content, and purity using validated analytical methods. Contaminant screening for heavy metals, pesticides, and mycotoxins is performed under GB 2762 and related national standards to ensure the material is suitable for efficacy studies.
Human Trial Samples
Samples for human feeding trials must be produced under Good Manufacturing Practice (GMP) conditions using the same formula and process as the batches used in animal experiments. Sufficient quantity must be supplied to cover the entire trial duration, dose groups, and retained reserve samples, with proper labeling of test and placebo products to preserve blinding.
Stability Samples
Accelerated and long-term stability samples support shelf-life claims and confirm that functional ingredient potency is maintained throughout the proposed expiration period.
Testing Items
Testing items are selected according to the declared function claim. Each function category has prescribed primary and secondary indicators, and the claim is judged on the aggregate outcome of these endpoints.
Immune Function Endpoints
- Delayed-type hypersensitivity reaction and organ index (spleen, thymus)
- Natural killer (NK) cell activity
- Antibody-forming cell assay and serum hemolysin levels
- Macrophage phagocytic capacity and carbon clearance test
- T and B lymphocyte proliferation response
Metabolic and Cardiovascular Endpoints
- Blood lipids: total cholesterol, triglycerides, and high-density lipoprotein cholesterol in diet-induced hyperlipidemia models
- Blood glucose: fasting glucose, glucose tolerance tests, insulin, and glycated hemoglobin
- Blood pressure: systolic and diastolic pressure measured by tail-cuff or telemetry methods
- Body weight, body fat percentage, and fat cell morphology for weight management claims
Neuropsychological and Sleep Endpoints
- Pentobarbital-induced sleep latency and duration, and subthreshold barbitolate testing for sleep improvement
- Morris water maze, step-down, step-through, and Y-maze performance for memory assessment
Antioxidant and Organ-Protection Endpoints
- Malondialdehyde (MDA) levels and lipid peroxidation markers
- Superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities
- Alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver index, and histopathology in chemical liver injury models
- Bone mineral density by dual-energy X-ray absorptiometry, calcium content, and biomechanical strength in bone density studies
Gastrointestinal and Nutritional Endpoints
- Intestinal flora population counts for microbiome regulation claims
- Small intestine propulsion rate and defecation frequency for digestive and laxative functions
- Gastric mucosa injury scoring for gastric protection claims
- Hemoglobin and red blood cell indices in nutritional anemia models
Human Trial Endpoints
For functions requiring human substantiation, endpoints include validated physiological indicators, symptom scores, quality-of-life questionnaires, and clinical safety monitoring such as blood pressure, heart rate, liver and kidney function, and routine blood and urine panels measured at baseline and endpoint.
Testing Methods
Animal Experiment Design
Animal studies primarily use mice and rats of specified strain, sex, and body weight range. Test designs include at least three dose groups plus a negative control group, with dose levels derived from the recommended human daily intake converted by body weight or surface area. Positive control groups may be added to validate model sensitivity. Test substances are typically administered by oral gavage for 30 days, with extended protocols of 45 to 90 days for certain functions. Animals are randomized, investigators are blinded where feasible, and all procedures follow GLP and laboratory animal welfare requirements.
Human Feeding Trial Protocols
Human trials require prior ethics committee approval and written informed consent from all participants. Eligible subjects are screened against strict inclusion and exclusion criteria and then assigned by randomized, double-blind, placebo-controlled design. Trial duration is commonly 30 to 60 days depending on the function claim. Primary and secondary indicators are measured at baseline and endpoint, adverse events are recorded throughout, and dietary compliance is monitored. Out-of-range safety values trigger suspension criteria defined in the protocol.
In Vitro and Mechanistic Assays
Cell-based models, enzyme activity assays, and radical scavenging tests such as DPPH and ABTS provide supporting mechanistic evidence. These assays help clarify the mode of action and strengthen the biological plausibility of the claimed function, although they generally serve as supplementary rather than standalone evidence.
Data Analysis and Claim Judgment
All data are subjected to appropriate statistical testing, including analysis of variance or non-parametric equivalents with pairwise comparisons. A positive claim judgment typically requires significant improvement in the prescribed primary indicators compared with the control group, evidence of a dose–response relationship, reproducibility across core endpoints, and absence of adverse effects at effective doses.
Applications
Functional evaluation testing serves multiple purposes across the product lifecycle:
- Registration dossiers for health food approval and the official certification mark required for legal function claims
- Function claim substantiation for e-commerce platforms, advertising review, and label compliance
- Formula optimization and screening during research and development
- Scientific documentation for cross-border trade and international market entry
- Post-market re-evaluation and renewal of existing product registrations
- Evidence packages for scientific publications and technical marketing materials
FAQ
What is health food functional evaluation testing?
It is a structured program of animal experiments, human feeding trials, and laboratory analyses that verifies whether a health food delivers its declared physiological function, such as immune support, fatigue relief, or blood sugar regulation, in order to support an official function claim.
Are both animal tests and human trials always required?
Requirements depend on the declared function. Some functions are judged on animal data alone, while others require positive results in both animal experiments and subsequent human feeding trials. The applicable technical guidelines define the mandatory study combination for each function claim.
How long does the evaluation process take?
Animal studies commonly require 30 to 90 days of dosing plus preparation and analysis. Human trials add screening, a 30 to 60 day intervention period, and data reporting. A complete functional evaluation package, including reporting and quality review, generally spans several months to one year.
What standards govern the testing?
Functional evaluation follows nationally issued technical guidelines for health function testing and assessment. Supporting safety and quality testing is conducted under the GB 15193, GB 4789, GB 5009, GB 2762, and GB 16740 standard series, with laboratory operations conforming to ISO/IEC 17025 and GLP principles.
How many samples are needed for testing?
Typical submissions include 10 to 30 kilograms of finished product for animal studies, plus additional GMP-produced batches for human trials and stability studies. Exact quantities are confirmed with the accredited third-party laboratory based on the test protocol and dose design.
Can a product fail evaluation even if it contains known active ingredients?
Yes. Claim approval depends on demonstrated efficacy at the recommended human dose in validated models, not merely on ingredient presence. Insufficient dose, poor bioavailability, or negative dose–response results can lead to a failed claim judgment despite a well-characterized formula.
